| 2024-05-20 | Sale | KalVista Pharmaceuticals, Inc. KALV | CHIEF MEDICAL OFFICER | 13,175 0.0309% | $11.76 | $154,997 | -1.3% | |
| 2024-02-20 | Sale | KalVista Pharmaceuticals, Inc. KALV | CHIEF MEDICAL OFFICER | 14,295 0.0422% | $14.12 | $201,774 | -13.77% | |
| 2023-11-20 | Sale | KalVista Pharmaceuticals, Inc. KALV | Chief Medical Officer | 7,985 0.0234% | $8.23 | $65,711 | +46.46% | |
| 2023-08-18 | Sale | KalVista Pharmaceuticals, Inc. KALV | Chief Medical Officer | 8,020 0.0233% | $10.73 | $86,045 | +5.29% | |
| 2023-05-18 | Sale | KalVista Pharmaceuticals, Inc. KALV | Chief Medical Officer | 2,780 0.0096% | $10.14 | $28,201 | +3.03% | |
| 2023-02-17 | Sale | KalVista Pharmaceuticals, Inc. KALV | Chief Medical Officer | 3,412 0.0114% | $7.66 | $26,136 | +18.6% | |
| 2022-11-18 | Sale | KalVista Pharmaceuticals, Inc. KALV | Chief Medical Officer | 722 0.0027% | $5.44 | $3,928 | +67.58% | |
| 2022-08-17 | Sale | KalVista Pharmaceuticals, Inc. KALV | Chief Medical Officer | 725 0.0029% | $14.96 | $10,847 | -47.04% |